YZi Labs, formerly known as Binance Labs, has made its first biotech move of 2025, investing in Renewal Bio, a regenerative medicine firm working on DNA-identical human tissues. The company’s mission is ambitious: to solve the global organ shortage using patient-derived stem cells. The partnership marks a major step for YZi Labs as it expands beyond its Web3 and AI roots into regenerative medicine, a field that merges cutting-edge biology with frontier technology. From Crypto Labs to Cell Labs The investment in Renewal Bio highlights YZi Labs’ ongoing transformation. Once focused purely on blockchain innovation, the $10 billion fund is
The post YZi Labs Makes First Biotech Investment of 2025, Backing Regenerative Medicine Startup Renewal Bio appeared first on The Merkle News.
